远程医疗筛查糖尿病视网膜病变的卫生经济学评价  

Health economic evaluation of telemedicine screening for diabetic retinopathy

作　　者：袁自由 解瑞 李会琳[1] 郝少峰[1] Yuan Ziyou;Xie Rui;Li Huilin;Hao Shaofeng(Department of Ophthalmology,Heji Hospital of Changzhi Medical College,Shanxi 046000,China)

机构地区：[1]长治医学院附属和济医院眼科,山西长治046000

出　　处：《国际眼科纵览》2023年第1期36-42,共7页International Review of Ophthalmology

基　　金：山西省科技厅重点研发计划项目(201903D321031)。

摘　　要：糖尿病视网膜病变(diabetic retinopathy,DR)是糖尿病常见的微血管并发症,是成年人低视力和致盲的主要原因。筛查可以使DR得到早期诊断和治疗,从而减少患者视力损害,提高生活质量。在组织大规模筛查前,国家医疗卫生部门通常会评估筛查的效果和筛查产生的社会成本消耗。近年来,许多国家和地区在基层卫生机构应用远程医疗开展DR筛查项目,并使用卫生经济学方法评价筛查的成本效益。通过对单个或者多个敏感性因素进行分析来制定筛查的个性化方案使成本效益最大化。近年国内外关于远程医疗在DR筛查领域的研究显示,大多数远程医疗在卫生经济学评价上具有成本效益,制定个性化筛查方案可将成本效益最优化。Diabetic retinopathy(DR)is a common microvascular complication of diabetes mellitus.It is the main cause of low vision and blindness in adults.Screening can enable early diagnosis and treatment of DR,thereby reducing the visual impairment and improving the quality of life.Before organizing large-scale screening,national health departments usually evaluate the effectiveness and the social cost of screening.Inrecent years,many countries and regions have applied telemedicine in primary health institutions to carry out DR screening projects,and used health economics methods to evaluate the cost-effectiveness of screening.Analyzing single or multiple sensitive factors to develop a personalized screening plan to maximize cost-effectiveness.Recent studies on telemedicine in the field of DR screening at home and abroad show that most telemedicine is cost-effective in health economic evaluation,and the development of personalized screening programs can optimize the cost-effectiveness.

关 键 词：卫生经济学 远程医疗 糖尿病视网膜病变 筛查 

分 类 号：R587.2[医药卫生—内分泌] R774.1[医药卫生—内科学]